Does social cognition change? Evidence after 4 years from the Italian Network for Research on Psychoses.

Follow-up recovery reliable and clinically significant change (RCSC) schizophrenia social cognition theory of mind

Journal

European psychiatry : the journal of the Association of European Psychiatrists
ISSN: 1778-3585
Titre abrégé: Eur Psychiatry
Pays: England
ID NLM: 9111820

Informations de publication

Date de publication:
11 01 2023
Historique:
pubmed: 12 1 2023
medline: 1 2 2023
entrez: 11 1 2023
Statut: epublish

Résumé

Deficits in social cognition (SC) are significantly related to community functioning in schizophrenia (SZ). Few studies investigated longitudinal changes in SC and its impact on recovery. In the present study, we aimed: (a) to estimate the magnitude and clinical significance of SC change in outpatients with stable SZ who were assessed at baseline and after 4 years, (b) to identify predictors of reliable and clinically significant change (RCSC), and (c) to determine whether changes in SC over 4 years predicted patient recovery at follow-up. The reliable change index was used to estimate the proportion of true change in SC, not attributable to measurement error. Stepwise multiple logistic regression models were used to identify the predictors of RCSC in a SC domain (The Awareness of Social Inference Test [TASIT]) and the effect of change in TASIT on recovery at follow-up. In 548 participants, statistically significant improvements were found for the simple and paradoxical sarcasm of TASIT scale, and for the total score of section 2. The reliable change index was 9.8. A cut-off of 45 identified patients showing clinically significant change. Reliable change was achieved by 12.6% and RCSC by 8% of participants. Lower baseline TASIT sect. 2 score predicted reliable improvement on TASIT sect. 2. Improvement in TASIT sect. 2 scores predicted functional recovery, with a 10-point change predicting 40% increase in the probability of recovery. The RCSC index provides a conservative way to assess the improvement in the ability to grasp sarcasm in SZ, and is associated with recovery.

Sections du résumé

BACKGROUND
Deficits in social cognition (SC) are significantly related to community functioning in schizophrenia (SZ). Few studies investigated longitudinal changes in SC and its impact on recovery. In the present study, we aimed: (a) to estimate the magnitude and clinical significance of SC change in outpatients with stable SZ who were assessed at baseline and after 4 years, (b) to identify predictors of reliable and clinically significant change (RCSC), and (c) to determine whether changes in SC over 4 years predicted patient recovery at follow-up.
METHODS
The reliable change index was used to estimate the proportion of true change in SC, not attributable to measurement error. Stepwise multiple logistic regression models were used to identify the predictors of RCSC in a SC domain (The Awareness of Social Inference Test [TASIT]) and the effect of change in TASIT on recovery at follow-up.
RESULTS
In 548 participants, statistically significant improvements were found for the simple and paradoxical sarcasm of TASIT scale, and for the total score of section 2. The reliable change index was 9.8. A cut-off of 45 identified patients showing clinically significant change. Reliable change was achieved by 12.6% and RCSC by 8% of participants. Lower baseline TASIT sect. 2 score predicted reliable improvement on TASIT sect. 2. Improvement in TASIT sect. 2 scores predicted functional recovery, with a 10-point change predicting 40% increase in the probability of recovery.
CONCLUSIONS
The RCSC index provides a conservative way to assess the improvement in the ability to grasp sarcasm in SZ, and is associated with recovery.

Identifiants

pubmed: 36628577
doi: 10.1192/j.eurpsy.2022.2356
pii: S0924933822023562
pmc: PMC9970151
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e10

Références

Schizophr Res. 2004 Dec 15;72(1):29-39
pubmed: 15531405
Schizophr Res. 2016 Oct;176(2-3):467-472
pubmed: 27443808
World Psychiatry. 2020 Jun;19(2):254-255
pubmed: 32394552
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Cogn Neuropsychiatry. 2007 May;12(3):198-212
pubmed: 17453901
Dev Psychol. 2021 Dec;57(12):2220-2233
pubmed: 34928670
Schizophr Res. 2011 Feb;125(2-3):143-51
pubmed: 21112743
Annu Rev Psychol. 2012;63:287-313
pubmed: 21838544
Psychol Med. 1996 May;26(3):521-30
pubmed: 8733211
World Psychiatry. 2020 Jun;19(2):151-172
pubmed: 32394571
J Clin Psychol. 2012 Dec;68(12):1303-12
pubmed: 22886716
Qual Life Res. 2002 Sep;11(6):509-16
pubmed: 12206571
Br J Psychiatry. 2019 Feb;214(2):103-112
pubmed: 30139394
Schizophr Res. 2017 Dec;190:136-143
pubmed: 28302395
Schizophr Bull. 2006 Oct;32 Suppl 1:S44-63
pubmed: 16916889
Am J Psychiatry. 2008 Feb;165(2):214-20
pubmed: 18172018
Schizophr Res. 2007 Jul;93(1-3):325-33
pubmed: 17498927
Cogn Neuropsychiatry. 2005 Mar;10(2):87-104
pubmed: 16571454
Schizophr Res. 1994 Feb;11(3):239-44
pubmed: 8193062
World Psychiatry. 2021 Feb;20(1):4-33
pubmed: 33432763
J Consult Clin Psychol. 1991 Feb;59(1):12-9
pubmed: 2002127
World Psychiatry. 2020 Jun;19(2):132-150
pubmed: 32394561
Psychol Med. 1998 Sep;28(5):1101-12
pubmed: 9794017
Psychol Sci. 2016 Nov;27(11):1428-1442
pubmed: 27670663
Schizophr Res. 2012 May;137(1-3):246-50
pubmed: 22356801
Eur Psychiatry. 2015 Jul;30(5):641-7
pubmed: 25758156
Clin Psychol Rev. 2016 Dec;50:108-137
pubmed: 27771557
Psychol Med. 2007 Apr;37(4):595-601
pubmed: 17094815
Schizophr Res. 2015 May;164(1-3):28-34
pubmed: 25749019
Schizophr Bull. 2008 Nov;34(6):1211-20
pubmed: 18184635
J Exp Child Psychol. 2016 Sep;149:98-115
pubmed: 26827097
J Abnorm Psychol. 1993 May;102(2):312-8
pubmed: 8315144
Front Psychol. 2019 Jan 08;9:2696
pubmed: 30671008
Schizophr Bull. 2012 Jun;38(4):854-64
pubmed: 21345917
Schizophr Bull. 2011 Sep;37 Suppl 2:S41-54
pubmed: 21860046
Schizophr Res. 2016 Aug;175(1-3):154-160
pubmed: 27209527
Front Psychiatry. 2018 Apr 24;9:157
pubmed: 29740360
Schizophr Bull. 2000;26(1):119-36
pubmed: 10755673
Psychol Med. 2012 Nov;42(11):2287-99
pubmed: 22475159
Am J Psychiatry. 2008 Feb;165(2):203-13
pubmed: 18172019
Psychol Med. 2016 Oct;46(13):2717-29
pubmed: 27649341
Schizophr Bull. 2011 Mar;37(2):300-5
pubmed: 20558531
Br J Psychiatry. 2005 Dec;187:523-8
pubmed: 16319404
Schizophr Bull. 1987;13(2):261-76
pubmed: 3616518
Schizophr Bull. 2012 Jun;38(4):865-72
pubmed: 21382881
World Psychiatry. 2020 Feb;19(1):81-91
pubmed: 31922687
Schizophr Res Cogn. 2015 Sep;2(3):133-139
pubmed: 27695675
Child Neuropsychol. 2013;19(6):615-29
pubmed: 22934659
Neurosci Biobehav Rev. 2019 Oct;105:212-219
pubmed: 31415864
PLoS One. 2015 Oct 28;10(10):e0141075
pubmed: 26510175
Pers Soc Psychol Bull. 2016 Aug;42(8):1045-62
pubmed: 27229679
Am J Psychiatry. 2005 Mar;162(3):441-9
pubmed: 15741458
Neurosci Biobehav Rev. 2011 Jan;35(3):573-88
pubmed: 20620163
World Psychiatry. 2014 Oct;13(3):275-87
pubmed: 25273301
Nord J Psychiatry. 2011 Sep;65(4):251-8
pubmed: 21062122
Schizophr Res. 2005 Dec 15;80(2-3):213-25
pubmed: 16137859
Schizophr Res. 2016 Mar;171(1-3):176-81
pubmed: 26785807
Psychiatry Res. 2013 Sep 30;209(2):129-35
pubmed: 23375626
Schizophr Res. 2015 Feb;161(2-3):392-8
pubmed: 25543332
JAMA Psychiatry. 2021 May 1;78(5):550-559
pubmed: 33566071
Disabil Rehabil. 2006 Dec 30;28(24):1529-42
pubmed: 17178616
Schizophr Bull. 2014 Jul;40(4):813-23
pubmed: 23728248
Schizophr Bull. 2013 Sep;39(5):979-92
pubmed: 22949733
Curr Opin Psychiatry. 2012 Mar;25(2):71-5
pubmed: 22249083
Psychol Med. 2002 Oct;32(7):1273-84
pubmed: 12420896
Conscious Cogn. 2008 Sep;17(3):778-89
pubmed: 18394921
Schizophr Res. 2006 Jul;85(1-3):142-50
pubmed: 16678388

Auteurs

Paola Rocca (P)

Section of Psychiatry, Department of Neuroscience, University of Turin, Turin, Italy.

Paola Rucci (P)

Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Cristiana Montemagni (C)

Section of Psychiatry, Department of Neuroscience, University of Turin, Turin, Italy.

Alessandro Rossi (A)

Section of Psychiatry, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Alessandro Bertolino (A)

Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy.

Eugenio Aguglia (E)

Psychiatry Unit, Department of Clinical and Molecular Biomedicine, University of Catania, Catania, Italy.

Carlo A Altamura (CA)

Department of Psychiatry, University of Milan, Milan, Italy.

Mario Amore (M)

Section of Psychiatry, Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics and Maternal and Child Health, University of Genoa, Genoa, Italy.

Ileana Andriola (I)

Department of Neurological and Psychiatric Sciences, University of Bari, Bari, Italy.

Antonello Bellomo (A)

Psychiatry Unit, Department of Medical Sciences, University of Foggia, Foggia, Italy.

Claudio Brasso (C)

Section of Psychiatry, Department of Neuroscience, University of Turin, Turin, Italy.

Bernardo Carpiniello (B)

Section of Psychiatry, Department of Public Health, Clinical and Molecular Medicine, University of Cagliari, Cagliari, Italy.

Elisa Del Favero (E)

Section of Psychiatry, Department of Neuroscience, University of Turin, Turin, Italy.

Liliana Dell'Osso (L)

Section of Psychiatry, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

Fabio Di Fabio (F)

Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy.

Michele Fabrazzo (M)

Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.

Andrea Fagiolini (A)

Department of Molecular Medicine and Clinical Department of Mental Health, University of Siena, Siena, Italy.

Giulia Maria Giordano (GM)

Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.

Carlo Marchesi (C)

Psychiatry Unit, Department of Neuroscience, University of Parma, Parma, Italy.

Giovanni Martinotti (G)

Department of Neuroscience and Imaging, G. D'Annunzio University, Chieti, Italy.

Palmiero Monteleone (P)

Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", Section of Neuroscience, University of Salerno, Salerno, Italy.

Maurizio Pompili (M)

Department of Neurosciences, Mental Health and Sensory Organs, S. Andrea Hospital, Sapienza University of Rome, Rome, Italy.

Rita Roncone (R)

Unit of Psychiatry, Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.

Rodolfo Rossi (R)

Section of Psychiatry, Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.

Alberto Siracusano (A)

Psychiatry and Clinical Psychology Unit, Department of Systems Medicine, Tor Vergata University of Rome, Rome, Italy.

Elena Tenconi (E)

Psychiatric Clinic, Department of Neurosciences, University of Padua, Padua, Italy.

Antonio Vita (A)

Psychiatric Unit, School of Medicine, University of Brescia, Brescia, Italy.
Department of Mental Health, Spedali Civili Hospital, Brescia, Italy.

Patrizia Zeppegno (P)

Psychiatric Unit, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.

Silvana Galderisi (S)

Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.

Mario Maj (M)

Department of Psychiatry, University of Campania "Luigi Vanvitelli", Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH